GenMark

Roche to Acquire GenMark Diagnostics for $1.8B

360Dx Index Declines 4 Percent in February, Ending Streak of Gains

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

GenMark Shares Rise on Acquisition Rumors

Fulgent Genetics, Genetron Pace Stock Price Increases as 360Dx Index Rises 10 Percent to Start 2021

JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More

GenMark Diagnostics Preliminary Q4 Revenues Rise 84 Percent on ePlex Molecular Diagnostics Sales

360Dx Index Jumps 31 Percent in 2020 as COVID-19 Shifts Attention to Dx Industry

Promising Coronavirus Vaccine News Leads to Share-Price Slide for Bevy of Dx Companies

GenMark Diagnostics Expanding Manufacturing to Meet Pent Up Demand for SARS-CoV-2, Respiratory Panel

GenMark Q3 Revenues More Than Double on Respiratory Panel Sales

GenMark Sees Jump in Preliminary Q3 Revenues, Nabs Respiratory Panel FDA Emergency Use Authorization

Siemens Healthineers Looking to Semi-Quantitative Assays for SARS-CoV-2 Serology Test Growth

GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

GenMark Diagnostics Q2 Revenues More Than Double on COVID-19 Testing

GenMark Diagnostics Preliminary Q2 Revenues Rise 118 Percent on SARS-CoV-2 Tests